Search Results - "Nicholson, Lizzie"
-
1
Impact of EMA regulatory label changes on hydroxyzine initiation, discontinuation and switching to other medicines in Denmark, Scotland, England and the Netherlands: An interrupted time series regression analysis
Published in Pharmacoepidemiology and drug safety (01-04-2021)“…Background Hydroxyzine is indicated for the management of anxiety, skin and sleep disorders. In 2015, the European Medicines Agency (EMA) concluded that…”
Get full text
Journal Article -
2
Impact of EU regulatory label changes for diclofenac in people with cardiovascular disease in four countries: Interrupted time series regression analysis
Published in British journal of clinical pharmacology (01-03-2021)“…Objective Due to cardiovascular safety concerns, the European Medicines Agency (EMA) recommended new contraindications and changes to product information for…”
Get full text
Journal Article -
3
Impact of EMA regulatory label changes on systemic diclofenac initiation, discontinuation, and switching to other pain medicines in Scotland, England, Denmark, and The Netherlands
Published in Pharmacoepidemiology and drug safety (01-03-2020)“…Purpose In June 2013 a European Medicines Agency referral procedure concluded that diclofenac was associated with an elevated risk of acute cardiovascular…”
Get full text
Journal Article